G oal: Inappropriate prescribing of a multiple therapeutic agents to patients with chronic conditions is very common in everyday practice. Adverse drug reactions (ADRs) are still considered as one of the main problems of drug therapy. We investigated idiosyncratic symptoms and signs of adverse drug reactions (ADRs) of the most frequent used combination of drugs among hospitalized patients prescribed polypharmacy. Methodology: A cross sectional study (design) was performed in Pharmacies "Eufarm Edal"in Tuzla from 2010 to 2011. Polypharmacy was defined as using ≥ 4 drugs. The total study sample of 166 examiners was interviewed with a questionnaire about ADRs which was developed special for study. Linear regression analyses was used to evaluate predictors of idiosyncratic signs of adverse drug reactions of the most prevalent drug combinations; using length of drugs in cases polypharmacy more than 6 months as independent variable. Age, sex, index of cumulative morbidity, drug number in polypharmacy, type of drug combination related pharmacological effects, type of hospital clinics were used as possible confounders. Results: The most common exposures to various drug combinations were: medication for high blood pressure and heart (62%), psychotropic drugs (59%), antacids (47%) and antibiotics (46%) among hospitalized patients with polypharmacy. Our results indicated that from 9.6% to 90.4% of hospitalized patients with polypharmacy had at least one suspicious long-term idiosyncratic drug combination use symptoms. The ADRs prevalence often used psychotropic drug combination was initiated suspected idiosyncratic adverse reactions: confusion, depression, anxiety, decreased libido and insomnia. Linear regression analyses also showed that it remains a very strange, and negative idiosyncratic and lacking therapeutic effects of use of antacids in conditions of polypharmacy. Conclusion: The toxicity of some drug combinations may sometimes be synergistic and be greater than the sum of the risks of toxicity of either agent used alone. In order to recognize and to prevent ADRs (including drug interactions), good communication between pharmacist and patient and/or physicians and patient is crucial, and prescribers should develop an effective therapeutic partnership with the patient and with fellow health professionals.
INTRODUCTION
Problems of adverse reactions are prevalent in hospitalized patients, while polypharmacy and increasing age were identified as two important risk factors (1) . Today there is also growing trend of symptomatic self-healing with non-prescription OTC drugs that are regularly available in pharmacies and complicate the problem (2) .
The term drug interaction means a change, whether in case of increase or decrease of the expected effect of a drug because of interaction between two or more therapeutic agents (3) . It is known that many drugs can interact in a positive outcome and have improved healing effect. Favorable interactions and clinically important interactions are in antihypertensives which are mostly of additive nature and enhancing the effect of antihypertensive drugs (4, 5, 6, 7) . Examples of useful therapeutic interactions are three-and four-drug combination therapy, anesthetics and analgesics in the reduction of pain, combined therapy of antiepileptic drugs, antidepressants, and nonsteroidal analgesics, miorelaxants and other drugs that are in combination with multiple analgesics such as opioids, prostaglandin inhibitors and other. Practice of synergic solving pain problems in patients is known as pain-killers or "analgesiasparing effect" (4) .
On the other hand there is little information on comprehensive approaches to study adverse drug reactions (ADSr) among hospitalized patients (8) . Side effects of ADRs or the inappropriate choice of drugs is prevalent in hospitalized patients and has a high incidence as 25% (9) . Undoubtedly, many risk factors contribute to the high prevalence rate of ADRs such as older age patients, polypharmacy, cumulative mortality index (8) (9) (10) . Among potential risk factors in the development of adverse drug interactions is still the most studied polypharmacy in geriatric patients (1, 2) .
It appears that a large number of studies on the ADRs during last 10-20 years had left no impression on the changes in clinical practice. However, the issue of adverse drug reactions remains unresolved (8) . The solution to this problem is of great importance in the practice of clinical medicine and become doctors and masters of the pharmacy obligation to devote more attention to adverse drug reactions and identifying risk factors of suspected idiosyncratic adverse drug reactions (1, 2) . The goal of this study was to investigate how the long-term use of the most common combination of drugs by the pharmacological effects is associated with the suspect, idiosyncratic ADRs; to determine the role of certain combinations of drugs with suspected, idiosyncratic ADRs.
MATeRIAL AND MeTHODS
A cross-sectional study was conducted during 2010-2011 in pharmacies "Eufarm Edal" Tuzla among patients who first came to the pharmacy for medication after discharge and completion of hospital treatment in various clinical departments of University Clinical Center in Tuzla and who have voluntarily joined the study. Material for research in order to select the participants (inclusion factor was polypharmacy with ≥ 4 drugs) in the initial stage were the data from hospital discharge lists. Also, from the discharge lists were used the following data: age, gender, medical history, an index of cumulative mortality, length of hospital stay (days), type of clinical/hospital department, type of medication according to the pharmacological action, treatment data, number of days of hospitalization, duration of drug exposure). To support the implementation of the objectives of the research questionnaire was used-"Who is at risk of polytherapy and adverse reactions of treatment". Respondents reported themselves with answers about ADRs symptoms, potential side effects of drugs, which were created specifically for this study. The answers were designed with the statement that can be answered wit yes or no (11) (12) (13) (14) (15) (16) (17) .
In the survey questionnaire was analyzed the positive (synergistic) interaction effects of combining therapeutic drugs (polytherapy) or negative suspected idiosyncratic therapeutic effect manifested by symptoms and signs of adverse events or polytherapy side effects. Synonyms of term idiosyncratic referred to: symptoms of unknown origin in a combination of drugs, or a sign of abnormal or unexpected drug reactions. Attention was paid to symptoms and signs of ill condition of the patient (morbidity) that would not be attributed to adverse drug reactions. In the study we followed the principles of toxicology, taking into account the duration of polytherapy exposure: acute exposure presents the use of the drug ≤ 30 days, and chronic over 6 months.
Sample
The study included with a voluntary agreement 304 adults, both sexes, aged 14-60 years. Including factors for the selection of respondents was their disease requiring drug treatment according to hospital clinical procedure and treatment with more than 4 drugs, and that they are not chronic alcoholics. In the total sample there was 138 of 304 (78+60) subjects who did not meet inclusive factors. The 78 patients as the hospital treatment had emergency diagnostic procedures, emergency surgical procedures, the transfer from one hospital department to another with unsolved comorbidity and drug treatment of choice. To none of these patients has been suggested drug treatment (number of medications = 0), but came to the pharmacy either to seek advice or drug from OTC group. Sixty patients who joined the study in the hospital were treated with <4 drugs. The final number of respondents was the 166.
Definitions Polytherapy is defined as daily consumption of ≥ 4 drugs. Polypharmacy (Lat. polypragmasia) is irrational and inappropriate provision of more therapeutic preparations for which there is no evidence of usefulness in the treatment (2-6). Cumulative morbidity index (CMU) is the size that determines the chronic morbidity of patients diagnosed with the diagnosed ≥ 4 diseases (2). The non-prescription pharmacy products or OTC (over the counter) drug are of natural origin, medical devices and drugs that are assumed to have a low degree of toxicity and wide therapeutic range (3) (4) (5) . So it can be used for the wellknown indications and to serve for selftreatment. OTC products include analgesics, antirheumatics drugs, vitamins and minerals, antihistamines, laxatives, and some beauty products that are sold only in pharmacies (most commonly used are analgesics).
Statistical analysis
All statistical analyzes were performed in SPSS 19.0 program. Standard tests of descriptive statistics were used with measures of central tendency and dispersion. Qualitative variables were tested by chi-square test with continuity correction. Multivariate linear regression analysis-ANOVA was used for the identification of susceptible role of commonly used combination of drugs (dependent variable), in terms of polypharmacy -while independent variable was prolonged exposure to polyphar-macy of >6 months. All tests were leveled with the level of statistical significance of 95% (p<0.05).
ReSULTS
In hospital conditions polypharmacy prevalence was 74% (n=166 respondents out of 226). Respondents (n=166) were in the average age of 46.36±9:53 (SD) years. Most of them belong to subgroup aged 46-55 years (51.8%) and the number of men were significantly higher (54.8%, p=0.001), which also means that men are more exposed to polypharmacy (Table 1 ). Index of cumulative morbidity was present in 55.5% of respondents. The frequency of polypharmacy was expressed by most common use of 4-7 medications 68.1%, 8-9 drugs were used by 21.1% of respondents, and from 10-13 medicine even 6.6% while in addition to this, occasionally used OTC 79.5%. Subjects were in total of 3367 days in hospital treatment, with an average of 20:28±21:49 (SD) days, and 95% confidence interval (95% CI) ranged from 16 
DISCUSSION
Polypharmacy is a ubiquitous problem that threatens the safety and health of the patients, but as the whole represents burden on the health care system. Prevalence of polypharmacy in our patients with an average age of 46.36±9:53 (SD) years, was very high 74%. Polypharmacy is most often associated with elderly patients (≥65 years) and its prevalence in geriatric patients, according to results of other authors is in the range Table 2 . The most commonly prescribed drugs combination of drugs of same pharmacological of 40-67%, which is inconsistent with our results (2, 4, 6) . Polypharmacy, high IKM and ADRs are represented in the younger age groups in our country (-19 years) in working age male population. It warns us of the complexity of this public health problem in our health care system and lacking preventive and promotional activities. It leaves questions for research, not only abut ADRs but risks for the job performance.
Our results indicate that 9.6% -90.4% of hospital-treated patients had at least one suspicious symptom of ADRs which is consistent with results of other authors (1). Numerous combinations of drugs often result in a change to their pharmacological activity or toxicity (18, 19, 20) . In one study, most suspected adverse reactions were initiated by antihypertensives and NSAIDs (18) . The most common is the use of anticoagulants (ASA) and antihypertensives (19) which is consistent with the results of our research. Antibiotics, anticoagulants, digoxin, oral hypoglycemic agents are the most common combinations of drugs within polypharmacy (21) (22) . Antineoplastic, NSAIDs, antiinflammatory analgesics cause 60% of all adverse events in hospital patients, and 70% of all adverse events occurring in the hospital (22) . However, in our study we found very high prevalence of the use of combinations of psychotropic drugs 59% (almost equal to the frequency with antihypertensive and cardiac medications (Table 2) . Frequently used combinations of psychotropic medications in polypharmacy initiated following suspected idiosyncratic adverse reactions: confusion, depression, anxiety, decreased libido, and insomnia. Drug resistance, tolerance or addiction to psychotropic medications is already known (8, 18) . It remains very strange, negative, idiosyncratic and lacking therapeutic effect of antacids in the conditions of polypharmacy because they have a susceptible role in the development of nausea, vomiting, erosive gastritis, abdominal pain, elevated transaminases and hepatotoxicity. Unknown so far is the positive effect of antibiotics on anxiety, libido, tremor, insomnia, and hypertensive crisis. We have never linked the occurrence of shivering with use of oral antidiabetic agents Table 3 . Chronic exposures to some of combination drugs with same pharmacological effects which was predictor of signs of idiosyncratic adverse drug effects (dependent variable duration of exposure to drugs/ duration of treatment more than 6 months; selection variable one of idiosyncratic sign of ADRs; independent variable the most frequent used combination of drugs) among hospitalized patients with polypharmacy (n=166) ANOVA, Linear regression analyses that are present in polypharmacy, or that a combination of ATLs can alleviate symptoms of hypertensive crisis. On the other hand, corticosteroids idiosyncratic alleviate symptoms of insomnia. More attention should be paid to resistance to the combination of ATLs in terms of long-term polypharmacy which was not identified in any discharge list but has been detected by our questionnaire.
In clinical practice, combinations of drugs with suspected ADRs can be still recommended in the treatment, but patients should be advised to closely monitor events such as the lack of therapeutic efficacy or toxicity. This is especially true for those drugs whose therapeutic effects can be reduced or increased if used within polypharmacy (5).
CONCLUSIONS
Our results reveal that the incidence of suspected and idiosyncratic ADRs symptoms in hospitalized patients treated with ≥4 drugs for >6 months is comparable to the results of similar studies in other developed countries, but our problem is more complex. Problems of adverse reactions according to the results of other authors are prevalent in hospitalized elderly patients (>65 years), and our results reveals male working age population particularly vulnerable at age >46 years (1) (2) (3) (4) (5) (6) (18) (19) (20) (21) (22) . It is necessary to conduct more studies in this area, especially on the side effects of psychotropic drugs that exhibit unintended effects opposite to the expected therapeutic effects, similar to antacids in the conditions of polypharmacy. This also belongs within the scope of farmakovigilance, and finally because of pharmacoeconomics imposes immense economic costs, so it would be appropriate to explore it in order to improve health care (cost-effective study) (7). Doctors and Masters of Pharmacy should conduct in future clinical trials, and focus more attention on risk factors for adverse reactions in polypharmacy.
